Clinical Trials Logo

Postoperative Fistula clinical trials

View clinical trials related to Postoperative Fistula.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02889393 Completed - Clinical trials for Postoperative Fistula

Teduglutide for Enterocutaneous Fistula (ECF)

Start date: January 31, 2019
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether Teduglutide is safe and feasible to be given for the treatment of enterocutaneous fistula (ECF). The hypothesis is that the drug will be well tolerated and will improve the volume of daily ECF output as well as improve the functional quality of life.